Related Experiment Video
Updated: Jul 20, 2025

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Peroxisome proliferator activated receptor-γ in osteoblasts controls bone formation and fat mass by regulating
Soohyun P Kim1, Avery H Seward1, Jean Garcia-Diaz1
1Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Abstract:
The nuclear receptor peroxisome proliferator activated receptor-γ (PPARγ) is a key contributor to metabolic function via its adipogenic and insulin-sensitizing functions, but it has negative effects on skeletal homeostasis. Here, we questioned whether the skeletal and metabolic actions of PPARγ are linked. Ablating Pparg expression in osteoblasts and osteocytes produced a high bone mass phenotype, secondary to increased osteoblast activity, and a reduction in subcutaneous fat mass because of reduced fatty acid synthesis and increased fat oxidation. The skeletal and metabolic phenotypes in Pparg mutants proceed from the regulation of sclerostin production by PPARγ. Mutants exhibited reductions in skeletal Sost expression and serum sclerostin levels while increasing production normalized both phenotypes. Importantly, disrupting the production of sclerostin synergized with the insulin-sensitizing actions of a PPARγ agonist while preventing bone loss. These data suggest that modulating sclerostin action may prevent bone loss associated with anti-diabetic therapies and augment their metabolic actions.
Insights
Peroxisome proliferator activated receptor-γ (PPARγ) links skeletal and metabolic functions. Modulating sclerostin action may prevent bone loss from anti-diabetic drugs and enhance their metabolic benefits.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Bone Biology
Background:
- Nuclear receptor PPARγ regulates adipogenesis and insulin sensitivity, crucial for metabolic health.
- PPARγ also negatively impacts skeletal homeostasis, creating a dichotomy in its physiological roles.
Purpose of the Study:
- To investigate the link between the skeletal and metabolic actions of PPARγ.
- To determine if PPARγ's effects on bone and fat are interconnected.
Main Methods:
- Genetic ablation of PPARγ (Pparg) in osteoblasts and osteocytes.
- Analysis of bone mass, osteoblast activity, subcutaneous fat mass, and fatty acid metabolism.
- Assessment of sclerostin (Sost) expression and serum levels.
Main Results:
- Pparg ablation in bone cells led to high bone mass and reduced subcutaneous fat.
- These phenotypes were linked to PPARγ's regulation of sclerostin production.
- Reduced sclerostin levels in mutants normalized both skeletal and metabolic parameters.
- Disrupting sclerostin production synergized with a PPARγ agonist, preventing bone loss and enhancing metabolic effects.
Conclusions:
- PPARγ's skeletal and metabolic actions are interconnected through sclerostin regulation.
- Modulating sclerostin offers a potential strategy to mitigate bone loss associated with anti-diabetic therapies.
- Targeting sclerostin may enhance the metabolic benefits of PPARγ agonists.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
TGF - β Signaling Pathway
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators

